Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Central venous catheter-related bloodstream infections in patients with hematological malignancies: Comparison of data from a clinical registry and a randomized controlled trial.

Schalk E, Teschner D, Hentrich M, Böll B, Panse J, Schmidt-Hieber M, Vehreschild MJGT, Biehl LM.

Infect Control Hosp Epidemiol. 2019 Dec 10:1-3. doi: 10.1017/ice.2019.335. [Epub ahead of print] No abstract available.

PMID:
31818338
2.

Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMT.

Schmidt-Hieber M, Engelhard D, Ullmann A, Ljungman P, Maertens J, Martino R, Rovira M, Shaw PJ, Robin C, Faraci M, Byrne J, Schäfer-Eckart K, Einsele H, Faber E, Rigacci L, Saccardi R, Balaguer-Rosello A, Isaksson C, Christopeit M, Tridello G, Wang J, Knelange N, Mikulska M, Cesaro S, Styczynski J.

J Neurol. 2019 Nov 16. doi: 10.1007/s00415-019-09578-5. [Epub ahead of print]

PMID:
31664549
3.

Impact of neutropenia on central venous catheter-related bloodstream infections in patients with hematological malignancies at the time of central venous catheter insertion: A matched-pair analysis.

Tölle D, Hentrich M, Pelzer BW, Kremer P, Einhell S, Schulz S, Böll B, Panse J, Schmidt-Hieber M, Teschner D, Schalk E.

Infect Control Hosp Epidemiol. 2019 Oct;40(10):1204-1206. doi: 10.1017/ice.2019.224. Epub 2019 Jul 29. No abstract available.

PMID:
31352911
4.

The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT.

Schmidt-Hieber M, Tridello G, Ljungman P, Mikulska M, Knelange N, Blaise D, Socié G, Volin L, Blijlevens N, Fegueux N, Yakoub-Agha I, Forcade E, Maertens J, Chevallier P, Passweg J, Cornelissen J, Russell N, Craddock C, Bourhis JH, Marchand T, Reményi P, Cahn JY, Michallet M, Montoto S, Kröger N, Glaß B, Styczynski J.

Ann Hematol. 2019 Jul;98(7):1755-1763. doi: 10.1007/s00277-019-03669-z. Epub 2019 Apr 16.

PMID:
30993417
5.

Management of febrile neutropenia in the perspective of antimicrobial de-escalation and discontinuation.

Schmidt-Hieber M, Teschner D, Maschmeyer G, Schalk E.

Expert Rev Anti Infect Ther. 2019 Dec;17(12):983-995. doi: 10.1080/14787210.2019.1573670. Epub 2019 Mar 11.

PMID:
30686067
6.

Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO).

Ruhnke M, Behre G, Buchheidt D, Christopeit M, Hamprecht A, Heinz W, Heussel CP, Horger M, Kurzai O, Karthaus M, Löffler J, Maschmeyer G, Penack O, Rieger C, Rickerts V, Ritter J, Schmidt-Hieber M, Schuelper N, Schwartz S, Ullmann A, Vehreschild JJ, von Lilienfeld-Toal M, Weber T, Wolf HH.

Mycoses. 2018 Nov;61(11):796-813. doi: 10.1111/myc.12838. Epub 2018 Sep 3. Review.

PMID:
30098069
7.

Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Schmidt-Hieber M, Bierwirth J, Buchheidt D, Cornely OA, Hentrich M, Maschmeyer G, Schalk E, Vehreschild JJ, Vehreschild MJGT; AGIHO Working Group.

Ann Hematol. 2018 Jan;97(1):31-49. doi: 10.1007/s00277-017-3183-7. Epub 2017 Nov 24. Review.

8.

Cyclophosphamide-based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial ReLApsE.

Baertsch MA, Schlenzka J, Lisenko K, Krzykalla J, Becker N, Weisel K, Noppeney R, Martin H, Lindemann HW, Haenel M, Nogai A, Scheid C, Salwender H, Fenk R, Graeven U, Reimer P, Schmidt-Hieber M, Goerner M, Schmidt-Wolf IGH, Klein S, Ho AD, Goldschmidt H, Wuchter P.

Eur J Haematol. 2017 Jul;99(1):42-50. doi: 10.1111/ejh.12888. Epub 2017 May 24.

PMID:
28370401
9.

Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd -line therapy for relapsed and refractory multiple myeloma - a phase II trial.

Mey UJ, Brugger W, Schwarb H, Pederiva S, Schwarzer A, Dechow T, Jehner P, Rauh J, Taverna CJ, Schmid M, Schmidt-Hieber M, Doerfel S, Fischer N, Ruefer A, Ziske C, Knauf W, Cathomas R, von Moos R, Hitz F, Sauter R, Hiendlmeyer E, Cantoni N, Bargetzi M, Driessen C.

Br J Haematol. 2017 Mar;176(5):770-782. doi: 10.1111/bjh.14481. Epub 2016 Dec 16.

PMID:
27983764
10.

The Diagnosis and Treatment of Multiple Myeloma.

Gerecke C, Fuhrmann S, Strifler S, Schmidt-Hieber M, Einsele H, Knop S.

Dtsch Arztebl Int. 2016 Jul 11;113(27-28):470-6. doi: 10.3238/arztebl.2016.0470. Review.

11.

Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.

Ullmann AJ, Schmidt-Hieber M, Bertz H, Heinz WJ, Kiehl M, Krüger W, Mousset S, Neuburger S, Neumann S, Penack O, Silling G, Vehreschild JJ, Einsele H, Maschmeyer G; Infectious Diseases Working Party of the German Society for Hematology and Medical Oncology (AGIHO/DGHO) and the DAG-KBT (German Working Group for Blood and Marrow Transplantation).

Ann Hematol. 2016 Sep;95(9):1435-55. doi: 10.1007/s00277-016-2711-1. Epub 2016 Jun 24.

12.

Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma.

Baertsch MA, Schlenzka J, Mai EK, Merz M, Hillengaß J, Raab MS, Hose D, Wuchter P, Ho AD, Jauch A, Hielscher T, Kunz C, Luntz S, Klein S, Schmidt-Wolf IG, Goerner M, Schmidt-Hieber M, Reimer P, Graeven U, Fenk R, Salwender H, Scheid C, Nogai A, Haenel M, Lindemann HW, Martin H, Noppeney R, Weisel K, Goldschmidt H.

BMC Cancer. 2016 Apr 25;16:290. doi: 10.1186/s12885-016-2321-2.

13.

CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Schmidt-Hieber M, Silling G, Schalk E, Heinz W, Panse J, Penack O, Christopeit M, Buchheidt D, Meyding-Lamadé U, Hähnel S, Wolf HH, Ruhnke M, Schwartz S, Maschmeyer G.

Ann Oncol. 2016 Jul;27(7):1207-25. doi: 10.1093/annonc/mdw155. Epub 2016 Apr 6.

14.

Multiple myeloma cells modify VEGF/IL-6 levels and osteogenic potential of bone marrow stromal cells via Notch/miR-223.

Berenstein R, Nogai A, Waechter M, Blau O, Kuehnel A, Schmidt-Hieber M, Kunitz A, Pezzutto A, Dörken B, Blau IW.

Mol Carcinog. 2016 Dec;55(12):1927-1939. doi: 10.1002/mc.22440. Epub 2015 Nov 24.

PMID:
27023728
15.

Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms.

Kutsch N, Marks R, Ratei R, Held TK, Schmidt-Hieber M.

Biomark Insights. 2015 Aug 16;10(Suppl 3):15-23. doi: 10.4137/BMI.S22434. eCollection 2015. Review.

16.

Multiple myeloma cells alter the senescence phenotype of bone marrow mesenchymal stromal cells under participation of the DLK1-DIO3 genomic region.

Berenstein R, Blau O, Nogai A, Waechter M, Slonova E, Schmidt-Hieber M, Kunitz A, Pezzutto A, Doerken B, Blau IW.

BMC Cancer. 2015 Feb 18;15:68. doi: 10.1186/s12885-015-1078-3.

17.

Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Maschmeyer G, Carratalà J, Buchheidt D, Hamprecht A, Heussel CP, Kahl C, Lorenz J, Neumann S, Rieger C, Ruhnke M, Salwender H, Schmidt-Hieber M, Azoulay E; Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology.

Ann Oncol. 2015 Jan;26(1):21-33. doi: 10.1093/annonc/mdu192. Epub 2014 May 15.

18.

Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO).

Penack O, Becker C, Buchheidt D, Christopeit M, Kiehl M, von Lilienfeld-Toal M, Hentrich M, Reinwald M, Salwender H, Schalk E, Schmidt-Hieber M, Weber T, Ostermann H.

Ann Hematol. 2014 Jul;93(7):1083-95. doi: 10.1007/s00277-014-2086-0. Epub 2014 Apr 29. Review.

19.

Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients - Review of the literature from a clinical perspective.

Biehl LM, Schmidt-Hieber M, Liss B, Cornely OA, Vehreschild MJ.

Crit Rev Microbiol. 2016;42(1):1-16. doi: 10.3109/1040841X.2013.875515. Epub 2014 Feb 4. Review.

PMID:
24495097
20.

Central venous catheter-related infections in hematology and oncology: 2012 updated guidelines on diagnosis, management and prevention by the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology.

Hentrich M, Schalk E, Schmidt-Hieber M, Chaberny I, Mousset S, Buchheidt D, Ruhnke M, Penack O, Salwender H, Wolf HH, Christopeit M, Neumann S, Maschmeyer G, Karthaus M; Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology.

Ann Oncol. 2014 May;25(5):936-47. doi: 10.1093/annonc/mdt545. Epub 2014 Jan 7.

PMID:
24399078
21.

CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT.

Schmidt-Hieber M, Labopin M, Beelen D, Volin L, Ehninger G, Finke J, Socié G, Schwerdtfeger R, Kröger N, Ganser A, Niederwieser D, Polge E, Blau IW, Mohty M.

Blood. 2013 Nov 7;122(19):3359-64. doi: 10.1182/blood-2013-05-499830. Epub 2013 Sep 13.

PMID:
24037724
22.

Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

Mousset S, Buchheidt D, Heinz W, Ruhnke M, Cornely OA, Egerer G, Krüger W, Link H, Neumann S, Ostermann H, Panse J, Penack O, Rieger C, Schmidt-Hieber M, Silling G, Südhoff T, Ullmann AJ, Wolf HH, Maschmeyer G, Böhme A.

Ann Hematol. 2014 Jan;93(1):13-32. doi: 10.1007/s00277-013-1867-1. Epub 2013 Sep 12.

23.

Diagnosis and management of gastrointestinal complications in adult cancer patients: evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

Vehreschild MJ, Vehreschild JJ, Hübel K, Hentrich M, Schmidt-Hieber M, Christopeit M, Maschmeyer G, Schalk E, Cornely OA, Neumann S; German Society of Hematology and Oncology.

Ann Oncol. 2013 May;24(5):1189-202. doi: 10.1093/annonc/mdt001. Epub 2013 Feb 10.

PMID:
23401037
24.

Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: a study in highly purified aberrant plasma cells.

Schmidt-Hieber M, Gutiérrez ML, Pérez-Andrés M, Paiva B, Rasillo A, Tabernero MD, Sayagués JM, Lopez A, Bárcena P, Sanchez ML, Gutiérrez NC, San Miguel JF, Orfao A.

Haematologica. 2013 Feb;98(2):279-87. doi: 10.3324/haematol.2011.060632. Epub 2012 Aug 28.

25.

In vitro effects of perifosine, bortezomib and lenalidomide against hematopoietic progenitor cells from healthy donors.

Schmidt-Hieber M, Dabrowski R, Aicher B, Lohneis P, Busse A, Tietze-Buerger C, Reufi B, Thiel E, Blau IW.

Invest New Drugs. 2012 Aug;30(4):1396-403. doi: 10.1007/s10637-011-9705-6. Epub 2011 Jul 13.

PMID:
21750922
26.

Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation.

Schwartz S, Vergoulidou M, Schreier E, Loddenkemper C, Reinwald M, Schmidt-Hieber M, Flegel WA, Thiel E, Schneider T.

Blood. 2011 Jun 2;117(22):5850-6. doi: 10.1182/blood-2010-12-325886. Epub 2011 Apr 12.

PMID:
21487110
27.

Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma.

Paiva B, Pérez-Andrés M, Vídriales MB, Almeida J, de las Heras N, Mateos MV, López-Corral L, Gutiérrez NC, Blanco J, Oriol A, Hernández MT, de Arriba F, de Coca AG, Terol MJ, de la Rubia J, González Y, Martín A, Sureda A, Schmidt-Hieber M, Schmitz A, Johnsen HE, Lahuerta JJ, Bladé J, San-Miguel JF, Orfao A; GEM (Grupo Español de MM)/PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas); Myeloma Stem Cell Network (MSCNET).

Leukemia. 2011 Apr;25(4):697-706. doi: 10.1038/leu.2010.320. Epub 2011 Jan 21.

PMID:
21252988
28.

In vitro cytotoxicity of the novel antimyeloma agents perifosine, bortezomib and lenalidomide against different cell lines.

Schmidt-Hieber M, Dabrowski R, Weimann A, Aicher B, Lohneis P, Busse A, Thiel E, Blau IW.

Invest New Drugs. 2012 Apr;30(2):480-9. doi: 10.1007/s10637-010-9576-2. Epub 2010 Nov 16.

PMID:
21080211
29.

CD117 expression in gammopathies is associated with an altered maturation of the myeloid and lymphoid hematopoietic cell compartments and favorable disease features.

Schmidt-Hieber M, Pérez-Andrés M, Paiva B, Flores-Montero J, Perez JJ, Gutierrez NC, Vidriales MB, Matarraz S, San Miguel JF, Orfao A.

Haematologica. 2011 Feb;96(2):328-32. doi: 10.3324/haematol.2010.031872. Epub 2010 Oct 22.

30.

Viral encephalitis after allogeneic stem cell transplantation: a rare complication with distinct characteristics of different causative agents.

Schmidt-Hieber M, Schwender J, Heinz WJ, Zabelina T, Kühl JS, Mousset S, Schüttrumpf S, Junghanss C, Silling G, Basara N, Neuburger S, Thiel E, Blau IW.

Haematologica. 2011 Jan;96(1):142-9. doi: 10.3324/haematol.2010.029876. Epub 2010 Sep 17.

31.

Immune reconstitution and cytomegalovirus infection after allogeneic stem cell transplantation: the important impact of in vivo T cell depletion.

Schmidt-Hieber M, Schwarck S, Stroux A, Ganepola S, Reinke P, Thiel E, Uharek L, Blau IW.

Int J Hematol. 2010 Jun;91(5):877-85. doi: 10.1007/s12185-010-0597-6. Epub 2010 May 21.

PMID:
20490728
32.

Cytogenetic studies in acute leukemia patients relapsing after allogeneic stem cell transplantation.

Schmidt-Hieber M, Blau IW, Richter G, Türkmen S, Bommer C, Thiel G, Neitzel H, Stroux A, Uharek L, Thiel E, Blau O.

Cancer Genet Cytogenet. 2010 Apr 15;198(2):135-43. doi: 10.1016/j.cancergencyto.2010.01.005. Erratum in: Cancer Genet Cytogenet. 2010 Jul 1;200(1):73.

PMID:
20362228
33.
34.

Prophylactic i.v. Igs in patients with a high risk for CMV after allo-SCT.

Schmidt-Hieber M, Schwarck S, Stroux A, Thiel E, Ganepola S, Uharek L, Blau IW.

Bone Marrow Transplant. 2009 Aug;44(3):185-92. doi: 10.1038/bmt.2008.435. Epub 2009 Jan 19.

PMID:
19151799
35.

Central nervous system infections in immunocompromised patients: update on diagnostics and therapy.

Schmidt-Hieber M, Zweigner J, Uharek L, Blau IW, Thiel E.

Leuk Lymphoma. 2009 Jan;50(1):24-36. doi: 10.1080/10428190802517740. Review.

PMID:
19031169
36.

Bendamustine, but not fludarabine, exhibits a low stem cell toxicity in vitro.

Schmidt-Hieber M, Busse A, Reufi B, Knauf W, Thiel E, Blau IW.

J Cancer Res Clin Oncol. 2009 Feb;135(2):227-34. doi: 10.1007/s00432-008-0453-8. Epub 2008 Aug 22.

PMID:
18719942
37.

Combined automated cell and flow cytometric analysis enables recognition of persistent polyclonal B-cell lymphocytosis (PPBL), a study of 25 patients.

Schmidt-Hieber M, Burmeister T, Weimann A, Nagorsen D, Hofmann WK, Thiel E, Schwartz S.

Ann Hematol. 2008 Oct;87(10):829-36. doi: 10.1007/s00277-008-0529-1. Epub 2008 Jun 28.

PMID:
18587574
38.

Intensified strategies to control vancomycin-resistant enterococci in immunocompromised patients.

Schmidt-Hieber M, Blau IW, Schwartz S, Uharek L, Weist K, Eckmanns T, Jonas D, Rüden H, Thiel E, Brandt C.

Int J Hematol. 2007 Aug;86(2):158-62.

PMID:
17875531
39.

Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation.

Blau IW, Schmidt-Hieber M, Leschinger N, Göldner H, Knauf W, Hopfenmüller W, Thiel E, Blau O.

Ann Hematol. 2007 Aug;86(8):583-9. Epub 2007 Apr 28.

PMID:
17468869
40.

Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma.

Schmidt-Hieber M, Blau IW, Trenschel R, Andreesen R, Stuhler G, Einsele H, Kanz L, Keilholz U, Marinets O, Beelen DW, Fauser AA, Volin L, Ruutu T, Uharek L, Fietz T, Knauf W, Hopfenmüller W, Thiel E, Freund M, Casper J.

Bone Marrow Transplant. 2007 Apr;39(7):389-96. Epub 2007 Feb 19.

PMID:
17310135
41.

Long-term follow-up of peripheral blood stem cell transplantation from mismatched related and unrelated donors.

Blau IW, Schmidt-Hieber M, Basara N, Hopfenmüller W, Bischoff M, Günzelmann S, Kirsten D, Schmetzer B, Roemer E, Kiehl MG, Thiel E, Fauser AA.

Clin Transplant. 2007 Jan-Feb;21(1):110-6.

PMID:
17302599
42.

Error management of emergency transfusions: a surveillance system to detect safety risks in day to day practice.

Schmidt-Hieber M, Schuster R, Nogai A, Thiel E, Hopfenmüller W, Notter M.

Transfus Apher Sci. 2006 Oct;35(2):125-30. Epub 2006 Oct 12.

PMID:
17045844
43.

A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma.

Schmittel A, Schmidt-Hieber M, Martus P, Bechrakis NE, Schuster R, Siehl JM, Foerster MH, Thiel E, Keilholz U.

Ann Oncol. 2006 Dec;17(12):1826-9. Epub 2006 Sep 13.

PMID:
16971664
44.

Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial.

Penack O, Schwartz S, Martus P, Reinwald M, Schmidt-Hieber M, Thiel E, Blau IW.

Ann Oncol. 2006 Aug;17(8):1306-12. Epub 2006 Jun 9.

PMID:
16766594
45.

Hydrops lysosomalis generalisatus--an underestimated side effect of hydroxyethyl starch therapy?

Schmidt-Hieber M, Loddenkemper C, Schwartz S, Arntz G, Thiel E, Notter M.

Eur J Haematol. 2006 Jul;77(1):83-5. Epub 2006 Apr 11.

PMID:
16608502
46.

Hemosiderin deposits in chronic graft-vs.-host disease related myopathy.

Schmidt-Hieber M, Okuducu AF, Stoltenburg G, Mackert BM, Benzian N, Thiel E, Blau IW.

Eur J Haematol. 2005 Dec;75(6):522-6.

PMID:
16313267
47.

Efficacy of the interleukin-2 receptor antagonist basiliximab in steroid-refractory acute graft-versus-host disease.

Schmidt-Hieber M, Fietz T, Knauf W, Uharek L, Hopfenmüller W, Thiel E, Blau IW.

Br J Haematol. 2005 Aug;130(4):568-74.

PMID:
16098072
48.

Spinal paraparesis due to leukemic meningitis in early-stage chronic lymphocytic leukemia.

Schmidt-Hieber M, Thiel E, Keilholz U.

Leuk Lymphoma. 2005 Apr;46(4):619-21.

PMID:
16019494
49.

A phase II study of bendamustine chemotherapy as second-line treatment in metastatic uveal melanoma.

Schmidt-Hieber M, Schmittel A, Thiel E, Keilholz U.

Melanoma Res. 2004 Dec;14(6):439-42.

PMID:
15577312
50.

[Breast tumor in hyperlipidemia].

Deuschle P, Schmidt-Hieber M.

Rofo. 2001 Nov;173(11):1053. German. No abstract available.

PMID:
11704918

Supplemental Content

Loading ...
Support Center